FDMT
4D Molecular Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.22
+2.28%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 39.36x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.66x
- Price / sales
- 7.34x
- Price / cash flow
- -4.33x
Enterprise value
- Enterprise value
- $353.1M
- EV / sales
- 3.84x
- EV / EBITDA
- -1.92x
- EV / EBIT
- -1.79x
- Market cap
- $675.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026